Reduced CFTR expression and carrier status for CFTR mutation, even in people without a clinical diagnosis of CF, are recognized as risk factors for colorectal cancer (CRC), cancers of the gallbladder and biliary tract, thyroid cancer, and unspecified NHL [42,43,44]. The gene discussed is CFTR; the disease is cystic fibrosis.